Charles Rudin

Cited by

	All	Since 2020
Citations	85896	50611
h-index	130	104
i10-index	405	322

11000

5500

2750

8250

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025234 336 421 468 470 508 589 873 1235 1594 1870 2254 2666 3797 4564 5204 6222 8208 10123 10541 10111 10314 1200

Public access

View all

299 articles

5 articles

available

not available

Based on funding mandates

Co-authors

John T. PoirierAssistant Professor, Perlmutter Cancer Center, NYU Langone HealthVerified email at nyulangone.org
Gregory J. Riely, MD, PhDMemorial Sloan Kettering Cancer CenterVerified email at MSKCC.org
Matthew HellmannMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Alexander DrilonMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Helena YuAssociate Attending, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
William TravisMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Ai NiMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Craig ThompsonMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Jamie E. ChaftMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Robert YauchGenentech, Inc.Verified email at gene.com
Eric Edison GardnerDamon Runyon Fellow; Weill Cornell MedicineVerified email at med.cornell.edu
David SolitCo-Director, Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Ronglai ShenMemorial Sloan-Kettering Cancer CenterVerified email at mskcc.org
Benjamin H. LokClinician-Scientist, Princess Margaret Cancer CentreVerified email at rmp.uhn.ca
malcolm brockJohns Hopkins School Of MedicineVerified email at jhmi.edu
Daniel Von HoffChief Scientific Officer US Oncology, Chief Scientific Officer TGen, Distinguished Professor MayoVerified email at tgen.org
John MinnaProfessor of Internal Medicine and Pharmacology, University of Texas Southwestern Medical CenterVerified email at utsouthwestern.edu
Phuoc T. Tran, MD, PhDUniversity of Maryland, Dept. of Radiation OncologyVerified email at umm.edu
Mark RatainLeon O. Jacobson Professor of Medicine, The University of ChicagoVerified email at uchicago.edu
Stephen B. BaylinJohns Hopkins University, Van Andel Research InstituteVerified email at vai.org

Charles Rudin

Chief, Thoracic Oncology, Memorial Sloan Kettering Cancer Center

Verified email at mskcc.org - Homepage

Cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer H Borghaei, L Paz-Ares, L Horn, DR Spigel, M Steins, NE Ready, ... New England Journal of Medicine 373 (17), 1627-1639, 2015	10170	2015
Tumor mutational load predicts survival after immunotherapy across multiple cancer types RM Samstein, CH Lee, AN Shoushtari, MD Hellmann, R Shen, ... Nature genetics 51 (2), 202-206, 2019	3488	2019
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs MG Kris, BE Johnson, LD Berry, DJ Kwiatkowski, AJ Iafrate, II Wistuba, ... Jama 311 (19), 1998-2006, 2014	1901	2014
Akt stimulates aerobic glycolysis in cancer cells RL Elstrom, DE Bauer, M Buzzai, R Karnauskas, MH Harris, DR Plas, ... Cancer research 64 (11), 3892-3899, 2004	1823	2004
Efficacy and safety of vismodegib in advanced basal-cell carcinoma A Sekulic, MR Migden, AE Oro, L Dirix, KD Lewis, JD Hainsworth, ... New England Journal of Medicine 366 (23), 2171-2179, 2012	1716	2012
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... Cancer discovery 8 (7), 822-835, 2018	1388	2018
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma DD Von Hoff, PM LoRusso, CM Rudin, JC Reddy, RL Yauch, R Tibes, ... New England Journal of Medicine 361 (12), 1164-1172, 2009	1371	2009
Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small-cell lung cancer profiled … H Rizvi, F Sanchez-Vega, K La, W Chatila, P Jonsson, D Halpenny, ... Journal of clinical oncology 36 (7), 633-641, 2018	1322	2018
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449 CM Rudin, CL Hann, J Laterra, RL Yauch, CA Callahan, L Fu, T Holcomb, ... New England Journal of Medicine 361 (12), 1173-1178, 2009	1235	2009
Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan F Innocenti, SD Undevia, L Iyer, P Xian Chen, S Das, M Kocherginsky, ... Journal of Clinical Oncology 22 (8), 1382-1388, 2004	1178	2004
Small-cell lung cancer CM Rudin, E Brambilla, C Faivre-Finn, J Sage Nature Reviews Disease Primers 7 (1), 3, 2021	1168	2021
Pneumonitis in patients treated with anti–programmed death-1/programmed death ligand 1 therapy J Naidoo, X Wang, KM Woo, T Iyriboz, D Halpenny, J Cunningham, ... Journal of Clinical Oncology 35 (7), 709-717, 2017	1157	2017
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer CM Rudin, S Durinck, EW Stawiski, JT Poirier, Z Modrusan, DS Shames, ... Nature genetics 44 (10), 1111-1116, 2012	1154	2012
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data CM Rudin, JT Poirier, LA Byers, C Dive, A Dowlati, J George, JV Heymach, ... Nature Reviews Cancer 19 (5), 289-297, 2019	1033	2019
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma RL Yauch, GJP Dijkgraaf, B Alicke, T Januario, CP Ahn, T Holcomb, ... Science 326 (5952), 572-574, 2009	1029	2009
Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer MD Hellmann, T Nathanson, H Rizvi, BC Creelan, F Sanchez-Vega, ... Cancer cell 33 (5), 843-852. e4, 2018	999	2018
Extracellular vesicle and particle biomarkers define multiple human cancers A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ... Cell 182 (4), 1044-1061. e18, 2020	988	2020
Combination epigenetic therapy has efficacy in patients with refractory advanced non–small cell lung cancer RA Juergens, J Wrangle, FP Vendetti, SC Murphy, M Zhao, B Coleman, ... Cancer discovery 1 (7), 598-607, 2011	750	2011
Lung cancer in never smokers: clinical epidemiology and environmental risk factors JM Samet, E Avila-Tang, P Boffetta, LM Hannan, S Olivo-Marston, ... Clinical Cancer Research 15 (18), 5626-5645, 2009	737	2009
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration H Kaneko, S Dridi, V Tarallo, BD Gelfand, BJ Fowler, WG Cho, ... Nature 471 (7338), 325-330, 2011	721	2011

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors